MAPK Signaling
MAPK Signaling(MAPK信号通路)
MAPK Signaling 相关产品(575)
- GC15299Staurosporine(CGP 41251)CAS: 62996-74-1纯度: >99.50%
Staurosporin 是一种小激酶抑制剂，是一种从细菌 Streptomyces staurosporeus 中提取的生物碱。
- GC15814Pamapimod (R-1503, Ro4402257)CAS: 449811-01-2纯度: >99.50%
An orally bioavailable inhibitor of p38α MAP kinase
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC14647 | SCH772984 HCl | - | - | |
A selective inhibitor of ERK1/2 | ||||
| GC14693 | CMK | 821794-90-5 | >99.50% | |
CMK 是一种 RSK2 激酶抑制剂，与 FMK 相比，具有相似的效力，但化学稳定性较低。 | ||||
| GC14853 | TC ASK 10 | 1005775-56-3 | >99.00% | |
A inhibitor of ASK1 | ||||
| GC14899 | AMG 548 | 864249-60-5 | - | |
An inhibitor of p38α MAPK | ||||
| GC14938 | PF-03394197(Oclacitinib) | 1208319-26-9 | - | |
A JAK family kinase inhibitor | ||||
| GC14982 | SD 169 | 1670-87-7 | >99.00% | |
A selective inhibitor of p38α and p38β MAP kinase | ||||
| GC15004 | URMC-099 | 1229582-33-5 | >99.50% | |
URMC-099作为一种基于7-氮杂吲哚的MLK3抑制剂，其IC50为14 nM，可特异性影响参与疾病病理生物学的特定aβ物种。 | ||||
| GC15044 | SCH772984 TFA | - | - | |
A selective inhibitor of ERK1/2 | ||||
| GC15061 | U0124 | 108923-79-1 | - | |
An inactive analog of U-0126 | ||||
| GC15240 | APS-2-79 | 2002381-31-7 | >99.00% | |
An inhibitor of KSR-dependent MAPK signaling | ||||
| GC15296 | ML 786 dihydrochloride | 1237536-18-3 | - | |
Raf kinase inhibitor | ||||
| GC15299 | Staurosporine(CGP 41251) | 62996-74-1 | >99.50% | |
Staurosporin 是一种小激酶抑制剂，是一种从细菌 Streptomyces staurosporeus 中提取的生物碱。 | ||||
| GC15352 | 8-CPT-Cyclic AMP (sodium salt) | 93882-12-3 | >98.00% | |
A cell-permeable cAMP analog | ||||
| GC15391 | Cercosporamide | 131436-22-1 | - | |
A potent inhibitor of fungal Pkc1 and mammalian Mnk isoforms | ||||
| GC15477 | DBM 1285 dihydrochloride | - | - | |
p38 MAPK inhibitor | ||||
| GC15611 | Rp-8-Br-PET-cGMPS | 185246-32-6 | >98.00% | |
An inhibitor of cGKI and cGKII | ||||
| GC15646 | PD 184161 | 212631-67-9 | - | |
A potent MEK1/2 inhibitor | ||||
| GC15693 | BIX 02188 | 334949-59-6 | >99.50% | |
A potent MEK5 inhibitor | ||||
| GC15814 | Pamapimod (R-1503, Ro4402257) | 449811-01-2 | >99.50% | |
An orally bioavailable inhibitor of p38α MAP kinase | ||||
| GC15818 | RAF265 | 927880-90-8 | >99.50% | |
A B-Raf and VEGFR2 inhibitor | ||||
| GC15924 | L-779,450 | 303727-31-3 | >98.50% | |
A B-Raf inhibitor | ||||
| GC16001 | SCH772984 | 942183-80-4 | >98.50% | |
SCH772984是一种新型的、有效的、ATP竞争性的ERK1和ERK2抑制剂，IC 50 值分别为4nM和1nM。 | ||||
| GC16007 | Methylthiouracil | 56-04-2 | >98.00% | |
甲基硫氧嘧啶是一种抗甲状腺药物。 | ||||
| GC16019 | SB 202474 | 172747-50-1 | - | |
A negative control for SB 202190 and SB 203580 | ||||